Showing 1 of 1 recruiting trials for “Crigler-Najjar syndrome type 1”
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
👨⚕️ Philippe LABRUNE, MD, PHD, APHP_Hopital Antoine BECLERE📍 1 site📅 Started Nov 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →